Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution

被引:144
作者
Anquetil, Celine [1 ,4 ]
Salem, Joe-Elie [3 ,5 ,6 ]
Lebrun-Vignes, Benedicte [3 ]
Johnson, Douglas B. [7 ]
Mammen, Andrew L. [8 ,9 ,10 ]
Stenzel, Werner [5 ,6 ,11 ]
Leonard-Louis, Sarah [2 ]
Benveniste, Olivier [1 ,4 ]
Moslehi, Javid J. [5 ,6 ,7 ]
Allenbach, Yves [1 ,4 ]
机构
[1] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Dept Internal Med & Clin Immunol, 82 Blvd Hop, F-75013 Paris, France
[2] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Dept Neuropathol, Paris, France
[3] Sorbonne Univ, Pitie Salpetriere Univ Hosp, Dept Pharmacol, Reg Ctr Pharmacovigilance, Paris, France
[4] Assoc Inst Myol, INSERM, Ctr Rech Myol, UMRS974, Paris, France
[5] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA
[6] Vanderbilt Univ, Med Ctr, Dept Med, Cardiooncol Program, Nashville, TN USA
[7] Vanderbilt Univ, Med Ctr, Dept Med, Div Oncol, Nashville, TN USA
[8] NIAMSD, Muscle Dis Unit, Lab Muscle Stem Cells & Gene Express, NIH, Bethesda, MD 20892 USA
[9] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[10] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[11] Charite, Dept Neuropathol, Berlin, Germany
关键词
antineoplastic agent; immunological; autoimmune diseases; myasthenia gravis; myocarditis; myositis;
D O I
10.1161/CIRCULATIONAHA.118.035898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:743 / 745
页数:3
相关论文
共 5 条
[1]   Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis [J].
Bertrand, Anne ;
Kostine, Marie ;
Barnetche, Thomas ;
Truchetet, Marie-Elise ;
Schaeverbeke, Thierry .
BMC MEDICINE, 2015, 13
[2]   Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study [J].
Dobloug, Gerd Cecilie ;
Svensson, John ;
Lundberg, Ingrid E. ;
Holmqvist, Marie .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (01) :40-47
[3]   Myasthenia triggered by immune checkpoint inhibitors: New case and literature review [J].
Gonzalez, Natalia L. ;
Puwanant, Araya ;
Lu, Angela ;
Marks, Stanley M. ;
Zivkovic, Sasa A. .
NEUROMUSCULAR DISORDERS, 2017, 27 (03) :266-268
[4]   Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial [J].
Herbst, Roy S. ;
Baas, Paul ;
Kim, Dong-Wan ;
Felip, Enriqueta ;
Perez-Gracia, Jose L. ;
Han, Ji-Youn ;
Molina, Julian ;
Kim, Joo-Hang ;
Arvis, Catherine Dubos ;
Ahn, Myung-Ju ;
Majem, Margarita ;
Fidler, Mary J. ;
de Castro, Gilberto, Jr. ;
Garrido, Marcelo ;
Lubiniecki, Gregory M. ;
Shentu, Yue ;
Im, Ellie ;
Dolled-Filhart, Marisa ;
Garon, Edward B. .
LANCET, 2016, 387 (10027) :1540-1550
[5]   Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis [J].
Moslehi, Javid J. ;
Salem, Joe-Elie ;
Sosman, Jeffrey A. ;
Lebrun-Vignes, Benedicte ;
Johnson, Douglas B. .
LANCET, 2018, 391 (10124) :933-933